Limited Offer: GLP $150 + NAD $100
100% online
FDA regulated pharmacies
Free expedited delivery
No hidden fees
Unlimited 24/7 support
100,000+ members

Home / Blog / GLP-1 & Weight Loss

June 1, 2026

7 min read

What Dose of Mounjaro Do You Start On? Complete 2.5mg to 15mg Titration Guide

What Dose of Mounjaro Do You Start On? Complete 2.5mg to 15mg Titration Guide

Key Takeaways

  • Mounjaro always starts at 2.5mg once weekly for Weeks 1โ€“4 so your digestive tract adapts with minimal nausea, constipation, or diarrhea.
  • Doses step up in 2.5mg increments at least 4 weeks apart (2.5mg โ†’ 5mg โ†’ 7.5mg โ†’ 10mg โ†’ 12.5mg โ†’ 15mg).
  • Licensed maintenance strengths are 5mg, 10mg, and 15mg โ€” many patients achieve sustainable weight loss without ever needing the maximum 15mg pen.

When starting Mounjaro (tirzepatide) for weight management, everyone begins at the 2.5mg once-weekly starter dose โ€” never jumping straight into higher strengths, even if you want fast results.

Standard 4-week Mounjaro titration pathway

Treatment WeeksWeekly Injection StrengthClinical Role
Weeks 1โ€“42.5mgIntroductory gut-adaptation starter dose (not a maintenance dose)
Weeks 5โ€“85mgFirst therapeutic & licensed maintenance strength
Weeks 9โ€“127.5mgStep-up bridge dose (if needed)
Weeks 13โ€“1610mgMid-tier licensed maintenance strength
Weeks 17โ€“2012.5mgUpper step-up bridge dose (if needed)
Weeks 21+15mgMaximum licensed weekly maintenance strength

Do you have to increase every 4 weeks up to 15mg?

No. At the end of each 4-week pen, your prescriber evaluates three things: how well your appetite and food noise are controlled, your steady weight-loss pace, and whether any GI side effects have settled. While 15mg produced the highest average weight loss in 72-week trials, 5mg and 10mg are both official maintenance doses โ€” and holding at the lowest dose that keeps you losing comfortably protects both tolerability and monthly cost.

Ready to find your personalized GLP-1 plan? Start our 3-minute medical consultation.

References

  1. U.S. Food and Drug Administration. Mounjaro (tirzepatide) prescribing information. 2026.
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205โ€“16.
Medical Editorial Review: Reviewed by the Amble Clinical Editorial Team. This article is for educational purposes only and does not replace an individualized consultation with a licensed healthcare professional.

Your personalizedweight care plan

Clinician-prescribed GLP-1 & metabolic care, 100% online.


Leave a Reply

Your email address will not be published. Required fields are marked *